Benthos Prime Central is a life science company headquartered in Houston, Texas, USA, offering a complete range of expert solutions to support research and development projects from inception to completion. As a scientific partner, we work closely with clients to understand their needs and objectives, providing tailored solutions to address specific challenges.

Our comprehensive services include cutting-edge research using genomics, transcriptomics, and epigenomics that encompass experimental and computational approaches. These include single-cell and spatial transcriptomics, single-cell DNA methylation and lncRNA-seq, SMART-seq, lncRNA discovery, RNA-based drug discovery, exosomes (transcriptomics & proteomics), as well as small and large animal studies. We are proud to offer scientific support from a diverse panel of leaders from academia and industry, who cover a range of human disease backgrounds and preclinical models.

BPC is committed to advancing the transformation of revolutionary basic discoveries into clinically impactful medicine. At BPC, our founders are steadfast in their conviction that a thorough and unique examination of project-specific data, executed with expedition, profundity, and astuteness, enables enhanced problem-solving in research and hastens breakthroughs that have significant impacts on society. With this guiding principle at the core of our operation, we blend our comprehensive scientific proficiency across the experimental, computational, and preclinical stages with robust backing from globally acknowledged key opinion leaders, positioning BPC in a unique and exceptional position to provide customized scientific services that meet the specific requirements of your project from inception to completion.